证券代码：000553(200553) 证券简称：安道麦 A（B） 公告编号：2025-34 号 安道麦股份有限公司 关于全资子公司之间提供担保的公告 本公司及董事会全体成员保证信息披露内容的真实、准确和完整，没有虚假记载、误 导性陈述或重大遗漏。 一、担保情况概述 为提升安道麦股份有限公司（以下简称"公司"）全资子公司Adama Agricultural Solutions Ltd.（以下简称"Solutions"）下属间接持股的全资子公司Adama Ukraine LLC （以下简称 "Adama Ukraine"）资金流动性、降低融资成本并对冲外汇风险，Solutions 同意为Adama Ukraine的如下用信业务向当地两家本土银行提供连带责任保证： 1. JSC "ING Bank Ukraine"银行不超过1,200万欧元的贷款业务（根据银行要求，担 保金额应比贷款金额高出15%，即1,380万欧元，以覆盖如应计利息、罚金等财务费用）; 2. Raiffeisen Bank JSC银行不超过1,200万欧元的信贷额度（信贷额度从700万欧元 增加至1200万欧元）。 根据《深圳证券交易所上市公司 ...

证券代码：000553（200553） 证券简称：安道麦A(B) 公告编号：2025-37号 安道麦股份有限公司 关联交易进展公告 本公司及董事会全体成员保证信息披露内容的真实、准确和完整，没有虚假记载、误导性 陈述或重大遗漏。 一、关联交易进展 2021年12月31日，安道麦股份有限公司（以下简称"公司"）与中国化工农化 有限公司（以下简称"农化公司"）签署《委托经营管理协议》（以下简称"原协 议"）。根据该协议，公司于托管期间内受托行使农化公司对安徽省石油化工集团 有限责任公司（以下简称"安徽石化"）所享有的管理权，并向农化公司收取托管 费（等值于50万美元的人民币/年），托管期限为二年（请参见公司于2022年1月4日 披露于巨潮资讯网的《关于与关联方签署委托经营管理协议的公告》）。 此后，公司、安道麦（中国）投资有限公司（以下简称"中国投"）与农化公 司签署了《补充协议》、《补充协议（二）》（以下合称"补充协议"），对托管 期限进行了延期（请参见公司于2023年12月30日、2024年12月19日披露于巨潮资讯 网的《第九届董事会第二十九次会议决议公告》、《第十届董事会第八次会议决议 公告》）。 2. ...

安道麦股份有限公司 公司章程及其附件修订对比表 （2025 年 10 月） 根据 《中华人民共和国公司法 （2023 修订）》《上市公司章程指引（2025）》《上市公司股东会规则》 等相关规定，安道麦股份 有限公司（以下简称"公司"）拟对 《安道麦股份有限公司章程》及其附件《安道麦股份有限公司股东大会议事规则》《安道麦股份有 限公司董事会议事规则》进行修订，具体修订情况如下： 一、公司章程修订对比表 | 修订前 | 修订后 | | --- | --- | | 第一条第一款 为维护公司、股东和债权人的合法权益，规范 | 第一条第一款 为维护公司、股东、职工和债权人的合法权益， | | 公司的组织和行为，根据《中华人民共和国公司法》(以下简称《公 | 规范公司的组织和行为，根据《中华人民共和国公司法》(以下简 | | 司法》)、《中华人民共和国证券法》(以下简称《证券法》)和其他 | 称《公司法》)、《中华人民共和国证券法》(以下简称《证券法》) | | 有关规定，制定《安道麦股份有限公司章程》(以下简称"本章程"）。 | 和其他有关规定，制定《安道麦股份有限公司章程》(以下简称"本 | | | 章程"）。 | ...

安道麦发布 2025 年第三季度及前九个月业绩 中国北京和以色列特拉维夫，2025 年 10 月 29 日——安道麦股份有限公司（以下简称"公司"，深 证 000553） 于今日公布了截至 2025 年 9 月 30 日的第三季度及前九个月财务业绩。 2025 年第三季度财务业绩概要： 2025 年前九个月财务业绩概要： 安道麦总裁兼首席执行官 Gaël Hili 表示："公司在第三季度继续改善财务业绩，销售额保持稳健， EBITDA 连续第六个季度实现同比增长，展现了 '奋进'转型计划支持价值创新战略的成效。我们继 续着力夯实运营基础，提高商务执行力，推动产品线的全面创新，为农民带来富有成果的影响，以期 安道麦实现长期可持续的盈利性增长。" 1 销售额为 9.33 亿美元，以美元计算同比持平，以人民币计算同比增长 1%，体现了销量同比增加 1%，价格同比下降 1%的综合影响； 调整后毛利为 2.57 亿美元，同比增长 14%；毛利率从去年同期的 24.2%提升至 27.6%，反映出成 本下降与销量增加共同产生的积极作用； 调整后息税及折旧摊销前利润（以下简称"EBITDA"）为 1.2 亿美元，同比增长 5 ...

一、召开会议的基本情况 1. 股东大会届次：2025 年第二次临时股东大会。 安道麦股份有限公司 证券代码：000553（200553） 证券简称：安道麦A(B) 公告编号：2025-35号 关于召开 2025 年第二次临时股东大会的通知 本公司及董事会全体成员保证信息披露的内容真实、准确、完整，没有虚假 记载、误导性陈述或重大遗漏。 2. 股东大会的召集人：董事会。公司于 2025 年 10 月 28 日召开的第十届董事会 第十五次会议，审议通过了《关于召开 2025 年第二次临时股东大会的议案》。 3. 本次会议的召集、召开符合《中华人民共和国公司法》《深圳证券交易所股票 上市规则》《深圳证券交易所上市公司自律监管指引第 1 号——主板上市公司规 范运作》等法律、行政法规、部门规章、规范性文件及《公司章程》的有关规定。。 4. 会议召开方式：本次股东大会采用现场表决和网络投票相结合的方式召开。 股东投票表决时，同一股份只能选择现场投票、网络投票中的一种方式，不能重 复投票。如果出现重复投票将按以下规则处理： （1）如果同一股份通过现场、网络重复投票，以第一次有效投票为准。 （2）如果同一股份通过网络多次重 ...

证券代码：000553（200553） 证券简称：安道麦A(B) 公告编号：2025-32号 安道麦股份有限公司 第十届监事会第七次会议决议公告 本公司及监事会全体成员保证信息披露的内容真实、准确、完整，没有虚假 记载、误导性陈述或重大遗漏。 会议以 3 票同意，0 票反对，0 票弃权的表决结果审议通过了议案。 特此公告。 1 安道麦股份有限公司监事会 2025 年 10 月 30 日 安道麦股份有限公司（以下简称"公司"或"本公司"）第十届监事会第七 次会议于 2025 年 10 月 23 日通过电子邮件方式通知了所有监事，并于 2025 年 10 月 28 日以视频及现场会议方式召开。会议应出席监事 3 人，实际出席监事 3 人。 本次会议的召开符合有关法律、行政法规、部门规章、规范性法律文件和公 司章程的规定。出席会议的监事审议并通过如下议案： 1. 关于《2025 年第三季度报告》的议案 经审核，监事会认为董事会编制和审议公司2025年第三季度报告的程序符合 法律、行政法规及中国证监会的规定，报告内容真实、准确、完整地反映了上市 公司的实际情况，不存在任何虚假记载、误导性陈述或者重大遗漏。 ...

证券代码：000553（200553） 证券简称：安道麦A(B) 公告编号：2025-31号 安道麦股份有限公司 第十届董事会第十五次会议决议公告 本公司及董事会全体成员保证信息披露的内容真实、准确、完整，没有虚假 记载、误导性陈述或重大遗漏。 安道麦股份有限公司（以下简称"公司"或"本公司"）第十届董事会第十 五次会议于 2025 年 10 月 24 日通过电子邮件方式通知了所有董事，并于 2025 年 10 月 28 日以视频及现场会议方式召开。本次会议应当出席董事 6 人，实际 出席董事 6 人。 本次会议的召开符合有关法律、行政法规、部门规章、规范性法律文件和公 司章程的规定。出席会议的董事审议并通过如下议案： 1. 关于《2025 年第三季度报告》的议案 会议以 6 票同意，0 票反对，0 票弃权的表决结果审议通过了本议案。 本议案已经公司董事会审计委员会审议通过。 2. 关于修订公司章程及其附件的议案 根据 《中华人民共和国公司法 （2023 修订）》《上市公司章程指引（2025）》 《上市公司股东会规则》等相关规定， 公司拟对《安道麦股份有限公司章程》 及其附件《安道麦股份有限公司股东大会议事规 ...

Financial Performance - The company's revenue for Q3 2025 was 6,654,225 thousand RMB, representing a 0.62% increase compared to the same period last year[13]. - The net loss attributable to shareholders for Q3 2025 was (342,454) thousand RMB, a 63.69% improvement year-over-year[13]. - The EBITDA for Q3 2025 was 741,865 thousand RMB, reflecting an 87.42% increase compared to the same period last year[13]. - Q3 2025 revenue was $933 million, showing a year-over-year change of 0%, while revenue for the first nine months was $3.025 billion, reflecting a year-over-year decrease of 0%[14]. - Operating revenue for the current period reached ¥21,678,425, an increase of 0.72% compared to ¥21,523,293 in the previous period[31]. - Operating loss decreased to ¥(436,660), improving from a loss of ¥(1,492,552) in the previous period[31]. - Net loss for the current period was ¥(422,806), significantly reduced from ¥(1,838,112) in the previous period, marking an improvement of approximately 77%[31]. - The total comprehensive loss for the current period was ¥(456,414), compared to ¥(2,067,869) in the previous period, indicating a significant reduction in losses[31]. - Basic earnings per share improved to ¥(0.1815) from ¥(0.7890) in the previous period[31]. Cash Flow and Expenses - The operating cash flow for the first nine months of 2025 was 2,373,860 thousand RMB, down 17.06% compared to the previous year[6]. - Financial expenses for the first nine months of 2025 totaled RMB 1.544 billion ($215 million), up from RMB 1.22 billion ($172 million) in the same period of 2024[20]. - Total financial expenses net for the first nine months of 2025 was RMB 1.54 billion ($215 million), compared to RMB 1.456 billion ($205 million) in 2024, reflecting an increase due to a one-time gain in the previous year[21]. - Cash flow from operating activities generated a net amount of ¥2,373,860, down from ¥2,862,232 in the previous period[32]. - Cash flow from investing activities resulted in a net outflow of ¥(942,083), compared to a net outflow of ¥(866,420) in the previous period[33]. - Cash flow from financing activities showed a net outflow of ¥(1,408,310), improving from a net outflow of ¥(2,703,059) in the previous period[33]. Assets and Liabilities - The total assets at the end of Q3 2025 were 49,930,633 thousand RMB, a decrease of 0.26% from the end of the previous year[6]. - As of September 30, 2025, total current assets amount to 26,262,900 thousand RMB, compared to 25,917,390 thousand RMB at the end of 2024[30]. - Total current liabilities increased to 20,468,589 thousand RMB from 18,013,457 thousand RMB year-over-year[30]. - Non-current assets total 23,667,733 thousand RMB, down from 24,142,387 thousand RMB at the end of 2024[30]. - Total liabilities amount to 31,477,288 thousand RMB, compared to 31,068,683 thousand RMB at the end of 2024[30]. - The company's equity attributable to shareholders is 18,453,345 thousand RMB, down from 18,991,094 thousand RMB at the end of 2024[30]. - Short-term borrowings increased by 34.65% to RMB 6.394 billion ($910 million) due to debt replacement[24]. - Long-term borrowings decreased by 33.40% to RMB 1.443 billion ($204 million) as a result of partial debt repayment[24]. Shareholder Information - Total number of common shareholders at the end of the reporting period is 36,215, including 24,837 A-share shareholders and 11,378 B-share shareholders[27]. - The largest shareholder, Syngenta Group Co., Ltd., holds 78.47% of the shares, totaling 1,828,137,961 shares[27]. - The company has no significant changes in the shareholding structure of the top 10 shareholders compared to the previous period[27]. Market Environment - The company noted that geopolitical tensions have not significantly impacted its supply capabilities or financial performance[11]. - The overall market environment remains challenging, with pricing pressures due to oversupply of raw materials affecting demand[10]. - The Asia-Pacific region saw a significant decline in Q3 2025 sales, down 16% to $225 million, with China specifically dropping 17% to $91 million[15]. - In Q3 2025, North America sales increased by 4% to $164 million, while sales for the first nine months rose by 15% to $659 million[15]. Operational Efficiency - The company reported a gross profit margin improvement, with operating costs decreasing by 5.67% in Q3 2025 compared to Q3 2024[13]. - Gross profit and gross margin improved year-over-year in Q3 2025 due to enhanced operational efficiency and reduced inventory costs, despite the negative impact of price declines[18]. - Operating expenses slightly decreased in Q3 2025, primarily due to the absence of one-time litigation costs from the previous year, although restructuring and consulting expenses increased[19]. - Research and development expenses for the first nine months of 2025 were 307,417 thousand RMB, a decrease of 3.93% year-over-year[12]. Financial Instruments - The company reported a significant decrease in derivative financial assets by 30.81% year-over-year, primarily due to the disposal and revaluation of derivatives[24]. Audit Information - The company did not undergo an audit for the third quarter report[34].

Core Viewpoint - The report highlights the growth trends in China's chemical pesticide raw material production, indicating a positive outlook for the industry from 2025 to 2031, with specific data on production volumes and growth rates [1]. Industry Summary - In August 2025, China's chemical pesticide raw material production reached 304,000 tons, marking a year-on-year increase of 3.8% [1]. - From January to August 2025, the cumulative production of chemical pesticide raw materials was 2.782 million tons, reflecting a cumulative growth of 7.2% [1]. - The report provides a comprehensive analysis of the pesticide industry, including market research and strategic insights for the period from 2025 to 2031 [1]. Company Summary - Listed companies in the pesticide sector include Yangnong Chemical (600486), Adama Agricultural Solutions A (000553), Xianda Co., Ltd. (603086), ST Hongtai (000525), Noposion (002215), Lier Chemical (002258), Runfeng Co., Ltd. (301035), and Xin'an Chemical (600596) [1].

Core Insights - The fungicide industry is experiencing rapid growth in China, driven by increasing public health awareness and environmental policies, with the market size projected to grow from 23.67 billion yuan in 2019 to 40.5 billion yuan by 2024, representing a compound annual growth rate (CAGR) of 11.34% [2][10] - The demand for environmentally friendly and biological fungicides is expected to rise significantly, particularly in the agricultural sector, which is the primary consumer market for fungicides [2][10] Industry Overview - Fungicides, also known as biocides, are chemical agents that effectively control or kill microorganisms such as bacteria, fungi, and algae [3] - The classification of fungicides can be based on application fields (industrial and agricultural), raw materials (inorganic, organic sulfur, organic phosphorus, etc.), usage methods (protective and therapeutic), and conduction characteristics (systemic and non-systemic) [3][8] Industry Policies - The Chinese fungicide industry is at a critical juncture influenced by policy changes and market transformations, with recent regulations aimed at promoting green and efficient fungicide production [5][7] - Key policies include the restriction of high-toxicity and high-residue pesticide production, as outlined in the "Industrial Structure Adjustment Guidance Catalog (2024 Edition)" [5][7] Industry Chain - The fungicide industry chain consists of upstream raw materials and production equipment, midstream research and manufacturing, and downstream applications in agriculture, forestry protection, urban greening, industrial corrosion prevention, and medical disinfection [8][10] Current Market Status - The global fungicide market is steadily expanding, with a projected market size of 19.704 billion USD in 2024, reflecting a year-on-year growth of 3.15% [10] - The growth is driven by the need for agricultural yield enhancement, public health protection, and food safety assurance, with expectations for the market to reach 22.942 billion USD by 2028 [10]